Antithrombotic Drugs Market 2017-2027

NEW YORK, Sept. 4, 2017 /PRNewswire/ -- Anticoagulants, Antiplatelet, Fibrinolytics

The revenue of the antithrombotic drugs market in 2016 is estimated at $18.08bn and is expected to grow at a CAGR of 7.9% in the first half of the forecast period. The anticoagulants segment accounted for the largest share of the market in 2016, this segment held 58.5% of the antithrombotic drugs market.


Read the full report: http://www.reportlinker.com/p05089829/Antithrombotic-Drugs-Market.html



How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 185-page report you will receive 84 tables and 69 figures – all unavailable elsewhere.
The 185-page report provides clear detailed insight into the antithrombotic drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
• Antithrombotic drugs market forecasts from 2017-2027
• This report also breaks down the revenue forecast for the main submarkets:
• Anticoagulants
• Antiplatelet agents
• Fibrinolytic treatments

This report provides the revenue forecast for these anticoagulant agents:
• Direct factor Xa inhibitors
• Heparins
• Direct thrombin inhibitors
• Vitamin K antagonists
• This report provides the revenue forecast for the leading products in this market:
• Xarelto
• Plavix
• Lovenox
• Eliquis
• Pradaxa
• Activase
• Brilinta/Brilique
• Aspirin Cardio
• Effient
• Aggrenox/Asasantin
• Fragmin
• Pletal
• Angiomax/Angiox
• Rest of Market

This report provides individual revenue forecasts to 2027 for these regional and national markets:
• US
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• Brazil
• Russia
• India
• Rest of World

This report provides discussion on pipeline products in various stages of clinical trials and regulatory approval.
Our study includes SWOT and STEP analysis of the antithrombotic drugs market.

Our study discusses the selected leading companies that are the major players in the antithrombotic drugs market:
• Bayer
• Bristol Myers Squibb
• Sanofi
• Boehringer-Ingelheim
• Roche (Genentech)
• AstraZeneca
• Eli Lilly
• Pfizer
• Otsuka Pharmaceutical
Read the full report: http://www.reportlinker.com/p05089829/Antithrombotic-Drugs-Market.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/antithrombotic-drugs-market-2017-2027-300513577.html

SOURCE Reportlinker